159 related articles for article (PubMed ID: 36498673)
1. MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD.
Mattinzoli D; Turolo S; Alfieri CM; Ikehata M; Caldiroli L; Armelloni S; Montini G; Agostoni C; Messa P; Vettoretti S; Castellano G
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498673
[TBL] [Abstract][Full Text] [Related]
2. MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation?
Mattinzoli D; Turolo S; Ikehata M; Vettoretti S; Montini G; Agostoni C; Conti C; Benedetti M; Messa P; Alfieri CM; Castellano G
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762869
[TBL] [Abstract][Full Text] [Related]
3. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
Emrich IE; Brandenburg V; Sellier AB; Schauerte J; Wiedenroth J; Untersteller K; Lennartz CS; Seiler-Mussler S; Wagenpfeil S; Fliser D; Heine GH
Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
[TBL] [Abstract][Full Text] [Related]
4. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
[TBL] [Abstract][Full Text] [Related]
5. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
[TBL] [Abstract][Full Text] [Related]
7. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
8. Biological variability of plasma intact and C-terminal FGF23 measurements.
Smith ER; Cai MM; McMahon LP; Holt SG
J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
[TBL] [Abstract][Full Text] [Related]
9. C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival.
Chu C; Elitok S; Zeng S; Xiong Y; Hocher CF; Hasan AA; Krämer BK; Hocher B
BMC Nephrol; 2021 Apr; 22(1):125. PubMed ID: 33832449
[TBL] [Abstract][Full Text] [Related]
10. The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans.
Bielesz B; Reiter T; Hammerle FP; Winnicki W; Bojic M; Gleiss A; Kieweg H; Ratzinger F; Sunder-Plassmann G; Marculescu R
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32823844
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
[TBL] [Abstract][Full Text] [Related]
12. Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.
Sharma S; Katz R; Ginsberg C; Bullen A; Vallon V; Thomson S; Moe OW; Hoofnagle AN; de Leeuw PW; Kroon AA; Houben AJHM; Ix JH
J Bone Miner Res; 2022 Jun; 37(6):1170-1178. PubMed ID: 35373859
[TBL] [Abstract][Full Text] [Related]
13. Disorders of Serum Polyunsaturated Fatty Acids in Renal Transplant Patients.
Sikorska-Wisniewska M; Mika A; Sledzinski T; Czaplinska M; Malgorzewicz S; Debska-Slizien A; Chmielewski M
Transplant Proc; 2020 Oct; 52(8):2324-2330. PubMed ID: 32334793
[TBL] [Abstract][Full Text] [Related]
14. Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.
Bansal S; Friedrichs WE; Velagapudi C; Feliers D; Khazim K; Horn D; Cornell JE; Werner SL; Fanti P
Nephrol Dial Transplant; 2017 Jun; 32(6):960-968. PubMed ID: 27836924
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Intravenous Iron, Inflammation and FGF23 in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.
Muras-Szwedziak K; Nowicki M
Kidney Blood Press Res; 2018; 43(1):143-151. PubMed ID: 29444509
[TBL] [Abstract][Full Text] [Related]
16. Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic Disorders.
Ramos P; Larson B; Ashrafzadeh-Kian S; Ito N; Kato H; Bornhorst JA; Algeciras-Schimnich A
Endocr Pract; 2023 Mar; 29(3):193-198. PubMed ID: 36627024
[TBL] [Abstract][Full Text] [Related]
17. Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.
Fořtová M; Hanousková L; Valkus M; Čepová J; Průša R; Kotaška K
Endocr Connect; 2022 Jan; 11(1):. PubMed ID: 34860179
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients.
Gao S; Xu J; Zhang S; Jin J
Blood Purif; 2019; 47 Suppl 1(Suppl 1):24-30. PubMed ID: 30699419
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
[TBL] [Abstract][Full Text] [Related]
20. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]